Matches in SemOpenAlex for { <https://semopenalex.org/work/W2153285983> ?p ?o ?g. }
- W2153285983 endingPage "7763" @default.
- W2153285983 startingPage "7757" @default.
- W2153285983 abstract "To evaluate the efficacy of reduced intensity conditioning (RIC) allogeneic transplant in 30 patients with poor-prognosis chronic lymphocytic leukemia (CLL) and/or high-risk molecular/cytogenetic characteristics.Eighty-three percent of patients had active disease at the moment of transplant. That is, 14 of the 23 patients analyzed (60%) had unmutated immunoglobulin variable heavy-chain gene (IgV(H)) status; 8 of 25 patients (32%) had 11q-, with four of them also displaying unmutated IgV(H); and six (24%) had 17p- (five were also unmutated).After a median follow-up of 47.3 months, all 22 patients alive are disease free; overall survival and event-free survival (EFS) at 6 years were 70% and 72%, respectively. According to molecular/cytogenetic characteristics, overall survival and EFS for unmutated CLL and/or with 11q- aberration (n = 13) were 90% and 92%, respectively, not significantly different to those with normal in situ hybridization, 13q- and +12, or mutated CLL (n = 7). All six patients with 17p deletion were transplanted with active disease, including three with refractory disease; all except one reached complete remission after the transplant and two are alive and disease free. Nonrelapse mortality (NRM) was 20%; more than two lines before transplant is an independent prognostic factor for NRM (P = 0,02), EFS (P = 0.02), and overall survival (P = 0.01). Patients older than 55 years have a higher risk of NRM (hazard ratio, 12.8; 95% confidence interval, 1.5-111). Minimal residual disease was monitored by multiparametric flow cytometry in 21 patients. Clearance of CD79/CD5/CD19/CD23 cells in bone marrow was achieved in 68% and 94% of the patients at days 100 and 360, respectively.According to these results, RIC allogeneic transplant could overcome the adverse prognosis of patients with unmutated CLL as well as those with 11q- or 17p-." @default.
- W2153285983 created "2016-06-24" @default.
- W2153285983 creator A5003420715 @default.
- W2153285983 creator A5005056682 @default.
- W2153285983 creator A5020702876 @default.
- W2153285983 creator A5020989412 @default.
- W2153285983 creator A5025894116 @default.
- W2153285983 creator A5031736300 @default.
- W2153285983 creator A5045740475 @default.
- W2153285983 creator A5053367608 @default.
- W2153285983 creator A5061223719 @default.
- W2153285983 creator A5066474429 @default.
- W2153285983 creator A5071568118 @default.
- W2153285983 creator A5083925677 @default.
- W2153285983 creator A5084354003 @default.
- W2153285983 date "2005-11-01" @default.
- W2153285983 modified "2023-10-17" @default.
- W2153285983 title "Allogeneic Transplant with Reduced Intensity Conditioning Regimens may Overcome the Poor Prognosis of B-Cell Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Variable Heavy-Chain Gene and Chromosomal Abnormalities (11q− and 17p−)" @default.
- W2153285983 cites W1479909146 @default.
- W2153285983 cites W1527161131 @default.
- W2153285983 cites W1965829723 @default.
- W2153285983 cites W1970509379 @default.
- W2153285983 cites W1973916894 @default.
- W2153285983 cites W1980653650 @default.
- W2153285983 cites W1986909355 @default.
- W2153285983 cites W1988371176 @default.
- W2153285983 cites W1993086920 @default.
- W2153285983 cites W1994075039 @default.
- W2153285983 cites W1995176938 @default.
- W2153285983 cites W1996602080 @default.
- W2153285983 cites W2002688127 @default.
- W2153285983 cites W2020491471 @default.
- W2153285983 cites W2030604738 @default.
- W2153285983 cites W2036637501 @default.
- W2153285983 cites W2048241782 @default.
- W2153285983 cites W2053895312 @default.
- W2153285983 cites W2069783189 @default.
- W2153285983 cites W2080951919 @default.
- W2153285983 cites W2083560922 @default.
- W2153285983 cites W2086637735 @default.
- W2153285983 cites W2095807890 @default.
- W2153285983 cites W2116249739 @default.
- W2153285983 cites W2126015095 @default.
- W2153285983 cites W2131706663 @default.
- W2153285983 cites W2132238257 @default.
- W2153285983 cites W2134253126 @default.
- W2153285983 cites W2162359545 @default.
- W2153285983 cites W2228874111 @default.
- W2153285983 cites W2254172637 @default.
- W2153285983 cites W2260423747 @default.
- W2153285983 cites W2316778105 @default.
- W2153285983 cites W2318933236 @default.
- W2153285983 cites W24911164 @default.
- W2153285983 cites W2558987954 @default.
- W2153285983 cites W4255733419 @default.
- W2153285983 cites W4297674123 @default.
- W2153285983 cites W60865865 @default.
- W2153285983 doi "https://doi.org/10.1158/1078-0432.ccr-05-0941" @default.
- W2153285983 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16278397" @default.
- W2153285983 hasPublicationYear "2005" @default.
- W2153285983 type Work @default.
- W2153285983 sameAs 2153285983 @default.
- W2153285983 citedByCount "122" @default.
- W2153285983 countsByYear W21532859832012 @default.
- W2153285983 countsByYear W21532859832013 @default.
- W2153285983 countsByYear W21532859832014 @default.
- W2153285983 countsByYear W21532859832015 @default.
- W2153285983 countsByYear W21532859832016 @default.
- W2153285983 countsByYear W21532859832017 @default.
- W2153285983 countsByYear W21532859832018 @default.
- W2153285983 countsByYear W21532859832019 @default.
- W2153285983 countsByYear W21532859832020 @default.
- W2153285983 countsByYear W21532859832021 @default.
- W2153285983 countsByYear W21532859832023 @default.
- W2153285983 crossrefType "journal-article" @default.
- W2153285983 hasAuthorship W2153285983A5003420715 @default.
- W2153285983 hasAuthorship W2153285983A5005056682 @default.
- W2153285983 hasAuthorship W2153285983A5020702876 @default.
- W2153285983 hasAuthorship W2153285983A5020989412 @default.
- W2153285983 hasAuthorship W2153285983A5025894116 @default.
- W2153285983 hasAuthorship W2153285983A5031736300 @default.
- W2153285983 hasAuthorship W2153285983A5045740475 @default.
- W2153285983 hasAuthorship W2153285983A5053367608 @default.
- W2153285983 hasAuthorship W2153285983A5061223719 @default.
- W2153285983 hasAuthorship W2153285983A5066474429 @default.
- W2153285983 hasAuthorship W2153285983A5071568118 @default.
- W2153285983 hasAuthorship W2153285983A5083925677 @default.
- W2153285983 hasAuthorship W2153285983A5084354003 @default.
- W2153285983 hasConcept C126322002 @default.
- W2153285983 hasConcept C143998085 @default.
- W2153285983 hasConcept C159654299 @default.
- W2153285983 hasConcept C203014093 @default.
- W2153285983 hasConcept C207103383 @default.
- W2153285983 hasConcept C2777938653 @default.
- W2153285983 hasConcept C2778461978 @default.
- W2153285983 hasConcept C2779823535 @default.
- W2153285983 hasConcept C2911091166 @default.
- W2153285983 hasConcept C44249647 @default.